FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Gilead CEO John C. Martin - CEO pay report

Tools

John C. Martin

John C. Martin - Gilead

Total Compensation: $10.8 million

Details: Martin received roughly $1 million in salary, $1.6 million in bonuses and $3,800 in "other" compensation. Most of Martin's slary came from stock and option awards valued at about $10.1 million. Overall, Martin's compensation fell 6.8 percent from 2006.

Gilead News:
FDA approves Letairis
Gilead touts Phase III Hep B results


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Gilead Sciences   Biotech CEO pay   John C. Martin